Real-World Study of Iruplinalkib in the Treatment of ALK-Positive Non-Small Cell Lung Cancer

Abroad (travel likely)Recruiting

Conditions

Non-small Cell Lung Cancer (NSCLC)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shandong Cancer Hospital and Institute, Jinan, Shandong, China
Contact: Study coordinator (Linlin Wang) · wanglinlinatjn@163.com · +8613793187739

Study leads

JinMing Yu, PhD
Principal Investigator
Shandong Cancer Hospital and Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCER

Non-Small Cell Lung Cancer · Exercise Training · Immunotherapy

Abroad (travel likely)Recruiting

Graz, Austria

Biomarkers for Risk Stratification in Lung Cancer

Nodule Solitary Pulmonary · Non-small Cell Lung Cancer

Abroad (travel likely)Recruiting

San Francisco, United States · San Francisco, United States

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Solid Tumor, Adult · Colorectal Cancer · Non Small Cell Lung Cancer

Abroad (travel likely)Recruiting

Gilbert, United States · Phoenix, United States